Ocular Therapeutix' Chief Scientific Officer Sells Shares Via Automatic Instruction
Jeffrey Heier, the Chief Scientific Officer of Ocular Therapeutix, Inc., executed a sale of company stock valued at approximately $24,747. This transaction was conducted through a pre-arranged automatic instruction to cover tax withholding related to vested restricted stock units. The news also highlights the company's recent Q1 2026 financial perf…